Akzo Nobel will accelerate growth

Baker, John
February 2007
ICIS Chemical Business;2/19/2007, Vol. 2 Issue 54, p5
Trade Publication
The article reports on the plan of Akzo Nobel to accelerate its growth as a focused coatings and chemicals business. The firm confirmed that it will begin the spin-off of its Organon BioSciences unit by the end of March 2007. Akzo board member Leif Darner emphasized that the company has a clear locus and a good financial position and intends to step up growth faster than the competition. Darner added that growth will come through geographic expansion, acquisitions and new products.


Related Articles

  • Akzo completes divestments. Bains, Elizabeth; Gibson, Jane // ICIS Chemical Business Americas;4/9/2007, Vol. 271 Issue 14, p14 

    The article reports on the completion of the chemical divestment program of Akzo Nobel. The company agreed to sell its methylamines and choline chloride business to Balchem. In 2005, Akzo Nobel announced its plans to sell off several businesses to focus more on its core chemical and coatings...

  • …but it won't rush into purchases. Jagger, Anna // ICIS Chemical Business;6/18/2007, Vol. 2 Issue 71, p44 

    The article reports on the decision of Akzo Nobel not to rush into purchases following its divestment of Organon BioSciences (OBS), according to CEO Hans Wijers. Wijers states that potential acquisition targets would need to fit strategically with the existing portfolio and create value for...

  • Akzo Nobel to Separate into Two Independent Companies.  // China Chemical Reporter;9/26/2006, Vol. 17 Issue 27, p7 

    The article reports on the plan of Akzo Nobel NV in China to separate into two independent companies after the shareholders approved the companies' proposal during an Extraordinary General Meeting. The EGM was cal led to ask shareholders to give their approval to the proposed separation, which...

  • Akzo Nobel to build chlorate in Brazil. Kapoor, Aarti; Chang, Joseph // ICIS Chemical Business Americas;5/28/2007, Vol. 271 Issue 21, p8 

    The article reports on an agreement signed by pulp and paper chemical business Eka Chemicals in 2007 to supply, store and handle all chemicals for a greenfield pulp mill in Brazil. The company will invest $67 million in the Hirozonte project at Tres Lagoas. The investment also includes the...

  • Akzo Nobel Is Ready to Grow Chemicals. Alperowicz, Natasha // Chemical Week;6/27/2007, Vol. 169 Issue 22, p14 

    The article reports on the reshaping of Akzo Nobel's business portfolio to improve its chemical business. The company is developing a multi-site chemical manufacturing facility at Ningbo, China and plans to move the pulp and paper sector to Tasmania, Indonesia and Russia. According to Leif...

  • Akzo's Chemicals Enter a New Era. Young, Ian // Chemical Week;11/1/2006, Vol. 168 Issue 36, p16 

    The article reports on the decision of Azko Nobel to become a manufacturer of chemicals and coatings after the split-off of its pharmaceuticals business Organon BioSciences (OBS) according to Akzo CEO Hans Wijers. It says that the separation of OBS follows after the completion of a major...

  • Akzo Nobel to sell Organon. Liming, Keith Tan; Ovrebekk, Hilde // ICIS Chemical Business Americas;3/19/2007, Vol. 271 Issue 11, p14 

    The article discusses the plan of Akzo Nobel to sell its stake in Organon BioSciences (OBS) to pharmaceutical group Schering-Plough. The deal, which is estimated at $14.5 billion, is expected to be closed in the second quarter of 2007. The deal increases the price of Akzo stock by 16 percent....

  • Akzo to Float 20%-30% of Pharma Business in Planned IPO; Shareholders Vote Next Month. Young, Ian // Chemical Week;8/23/2006, Vol. 168 Issue 28, p11 

    The article announces the plan of Akzo Nobel to float 20% to 30% of its combined pharmaceutical and veterinary medicines business under a previously announced initial public offering (IPO). Shareholders will vote on plans to split Akzo into two separately quoted companies. Organon BioSciences...

  • IPO of Organon BioSciences Imminent. van der Zanden, Tim // China Chemical Reporter;3/6/2007, Vol. 18 Issue 7, p10 

    The article focuses on an announcement made by Akzo Nobel NV regarding its plan of launching an initial public offering (IPO) for the firm Organon BioSciences. A listing of about 20 to 30 percent of Organon BioSciences' shares on Euronext Amsterdam was done by Akzo. According to Hans Wijers,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics